May 26, 2018 3:22 AM ET


Company Overview of Aptalis Pharma Canada ULC

Company Overview

Aptalis Pharma Canada ULC develops therapies for cystic fibrosis and gastrointestinal disorders in the United States, the European Union, and Canada. It manufactures and commercializes pharmaceutical products, including ZENPEP, ULTRASE, and VIOKASE products for the treatment of exocrine pancreatic insufficiency (EPI); PANZYTRAT for use in the treatment of EPI and pancreatic enzyme deficiency; CANASA for the treatment of ulcerative proctitis; and SALOFALK for the treatment of inflammatory bowel diseases, such as ulcerative colitis, ulcerative proctitis, and Crohn’s disease. The company was incorporated in 2007 and is based in Mont-Saint-Hilaire, Canada. Aptalis Pharma Canada ULC operates as a...

597 Laurier Boulevard

Mont-Saint-Hilaire, QC J3H 6C4


Founded in 2007

875 Employees





Key Executives for Aptalis Pharma Canada ULC

Aptalis Pharma Canada ULC does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
1113131 B.C. Ltd. Americas
1127466 B.C. Ltd. Americas
1600978 Ontario Inc. Americas
48North Cannabis Corporation Americas
4everPets Ltd. Americas

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Aptalis Pharma Canada ULC, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at